Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
NCT05627219 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2026-05-15
Summary
This trial evaluates whether a network of peer genetic coaches is useful for addressing disparities in genetic testing and screening among African American men with prostate cancer that has spread from where it first started (primary site) to other places in the body (metastatic). While genetic testing has become central to prostate cancer care, African American men are less likely seek testing due to lack of awareness, cultural beliefs, financial limitations, fear of discrimination, and mistrust in the healthcare system. A network of peer genetic coaches may help address barriers, beliefs, and needs of African American men in the community and provide navigation to increase engagement in genetic testing.
Conditions
- Metastatic Prostate Carcinoma
- Stage IIIB Prostate Cancer AJCC v8
- Stage IIIC Prostate Cancer AJCC v8
- Stage IV Prostate Cancer AJCC v8
Interventions
- BEHAVIORAL
-
Training and Education
Undergo training and education
- OTHER
-
Educational Intervention
Receive educational booklet
- PROCEDURE
-
Discussion
Attend discussion with peer genetic coach
Sponsors & Collaborators
-
Thomas Jefferson University
lead OTHER
Principal Investigators
-
Amy Leader, DrPh, MPH · Thomas Jefferson University
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-06-03
- Primary Completion
- 2026-09-30
- Completion
- 2026-09-30
Countries
- United States
Study Locations
More Related Trials
-
Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners
NCT04189770 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular Mechanisms Underlying Prostate Cancer Disparities
NCT02229565 ·Status: COMPLETED
-
The Effect of the Prostate Cancer Foundation Screening Guidelines for Black Men on Intention to Screen in Faith-based Communities
NCT06838325 ·Status: COMPLETED ·Phase: NA
-
Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study
NCT04447703 ·Status: COMPLETED ·Phase: NA
-
Prostate Cancer Genius App Education and Home-based PSA Screening for African American Men
NCT05331638 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model
NCT03934606 ·Status: COMPLETED
-
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
NCT05327465 ·Status: RECRUITING ·Phase: NA
-
Addressing Health Literacy With a Tailored Survivorship Care Plan
NCT06674863 ·Status: RECRUITING ·Phase: NA
-
Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men
NCT06541210 ·Status: RECRUITING ·Phase: NA
-
Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer
NCT07073794 ·Status: RECRUITING ·Phase: PHASE2
-
Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer
NCT01940276 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer
NCT00958477 ·Status: COMPLETED ·Phase: PHASE1
-
Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery
NCT00977457 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer
NCT06527690 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer
NCT03833921 ·Status: RECRUITING ·Phase: PHASE2
-
Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men
NCT00354497 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer
NCT00959023 ·Status: UNKNOWN
-
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer
NCT03963739 ·Status: COMPLETED
-
Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)
NCT03807492 ·Status: COMPLETED
-
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer
NCT00967954 ·Status: UNKNOWN ·Phase: NA
-
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
NCT06592924 ·Status: RECRUITING ·Phase: PHASE3
-
Assessment of Research Digest Impact for Minority with Prostate Cancer, MiCAP Phase III Study
NCT05895279 ·Status: COMPLETED ·Phase: NA
-
EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression
NCT04266431 ·Status: COMPLETED ·Phase: NA
-
A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy
NCT06044025 ·Status: RECRUITING ·Phase: PHASE1
-
Precision Medicine in the Prostate Cancer Care Pathway
NCT04763317 ·Status: RECRUITING